Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 18, 1997

View Archived Issues

Ortho synthesizes inhibitors of serine proteases

COR Therapeutics discloses factor Xa inhibitors

Abbott discloses nicotinic cholinergic channel modulators

Adenosine kinase inhibitors prepared by Gensia

Immunosuppressants discovered by Merck & Co.

Yeda discloses peptides for myasthenia gravis

Inhibitors of cell adhesion disclosed by Tanabe

TCR peptides for MS reported by Connective Therapeutics

Progen's lead compound shows promise for cancer/metastasis

Japanese introduction for new formulation of epoetin alfa

Ibustrin for diabetic vascular complications

Mechanism of antitumor effect of natural lipopolysaccharide

AD diagnostic reaches market

Aphton and Pasteur Merieux Connaught form immunotherapy product alliance

AEterna clarifies Neovastat clinical development program

New dosage strengths of Coumadin available

Antidepressant with minimal impact on sexual function introduced

Immunomedics' LeukoScan approved for European market

Bard presents new bladder cancer diagnostic test

Peptide Therapeutics/SmithKline Beecham vaccine technology alliance

MedImmune's HPV vaccine enters phase I

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...